ClinicalTrials.gg
Active, not recruitingNCT06090734Updated Apr 21, 2026

Development and Evaluation of 'My Voice': A Randomized Controlled Trial

An interventional study of My Voice in Advance Care Planning and Heart Failure, sponsored by Duke-NUS Graduate Medical School. Active, not recruiting at 1 site in Singapore. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by Duke-NUS Graduate Medical School · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
244
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 62 studies in Heart Failure with a site in Singapore — 6 open to participants now, 14 under way, 2 of them phase 3. Heart Failure · Singapore.

Planned enrollment
26th of 46
244 · median 310
Started
2024
with 4 others
No phase
17 of 62
3 open now
Primary completion
2027-03
later than 6 of 13 live
Registered
55th of 62
by date
Lead sponsor
3 of 62
Duke-NUS Graduate Medical School

Among the 62 studies in Heart Failure with a site in Singapore, this one is the 26th largest by planned enrollment of the 46 interventional ones that give a count, is one of 5 that started in 2024, is one of 17 with no phase, reaches primary completion later than 6 of the 13 other live ones, and was the 55th registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

6 of the 62 studies in Heart Failure with a site in Singapore are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 21 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 62 studies in Heart Failure with a site in Singapore, or all of them as a file.
02

Study summary

The study aims to develop and evaluate a web-based interactive platform (called 'My Voice') that helps to educate patients with heart failure and their caregivers about heart failure, identify their goals for end-of-life care, and share these with their caregivers and doctors.

Read the detailed description

The research study consists of 3 phases:

  1. Usability testing - to assess the usability of 'My Voice' with patients with heart failure, their caregivers and healthcare providers,
  2. Pilot testing - to test the feasibility of implementation and workflow of 'My Voice' and the survey questionnaires with a small group of participants and,
  3. Randomized controlled trial- to evaluate the effectiveness of 'My Voice' with a control group who do not receive the intervention in improving patient outcomes
03

Conditions studied

  • Advance Care Planning
  • Heart Failure

Browse trials for

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- The inclusion criteria for patients are

  1. Age ≥ 21 years old
  2. Singaporean or Permanent Resident
  3. Diagnosed with heart failure
  4. Symptoms classified under class II (with an of less than or equal to 35%), III or IV
  5. Intact cognition determined through the Abbreviated Mental Test (AMT) (for pilot testing and main RCT)
  6. Ability to speak and read English, Mandarin or Malay
  7. Willing to complete a web intervention
  8. Easily contactable via mobile phone or landline
  9. Have a permanent address in Singapore for at least the next 1 year
  10. Not recruited in a previous phase of the study

The inclusion criteria for caregivers are

  1. Age ≥ 21 years old
  2. Nominated as a healthcare spokesperson by the patient or the main decision maker for the patient (for intervention arm only)
  3. Ability to speak and read English, Mandarin or Malay
  4. Willing to complete a web intervention
  5. Easily contactable via mobile phone or landline
  6. Have a permanent address in Singapore for at least the next 1 year

Exclusion criteria

Exclusion criteria for caregivers are:

a) domestic helper

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
244 participants (estimated)

Study arms

  • Experimental
    My Voice

    Intervention arm patients will complete the patient version of 'My Voice' at least once every 3 months for 1 year or until they pass away (whichever is earlier). Caregivers of patients in the intervention arm will complete the caregiver version of 'My Voice' at least once every 3 months for 1 year (or until the patient passes away, whichever is earlier).

    Other: My Voice

  • No intervention
    Control

    Control arm patients and caregivers will receive usual care.

Interventions

  • OtherMy Voice

    The web intervention educates patients about their illness and supports them to make their own Advance Care Planning decisions, update these decisions frequently as their clinical condition changes, and to make the ACP process easier and more accessible. The intervention aims to shift implementation of ACP from a provider-led one-time model to a patient-led dynamic model.

06

What researchers measure

Primary outcomes

  1. Proportion of patients who have ACP discussions with their treating doctor at least once during the study period

    will be assessed from medical records and survey

    Time frame: 1 year from data collection

  2. Proportion of patients who have ACP discussions with their caregivers

    will be assessed from the survey

    Time frame: 1 year from data collection

  3. Proportion of patients who prefer life-extending treatments

    will be assessed from the survey

    Time frame: 1 year from data collection

Secondary outcomes

  1. Proportion of patients with psychological distress

    will be assessed from the survey

    Time frame: 1 year from data collection

  2. Peace and acceptance scores

    will be assessed from the survey

    Time frame: 1 year from data collection

  3. Proportion of patients having decision maker

    will be assessed from the survey

    Time frame: 1 year from data collection

07

Study locations

1 site
08

References and documents

Publications

  • Malhotra C, Yee A, Ramakrishnan C, Kaurani SN, Chua I, Lakin JR, Sim D, Balakrishnan I, Ling VGJ, Weiliang H, Ling LF, Pollak KI. Development and Usability of an Advance Care Planning Website (My Voice) to Empower Patients With Heart Failure and Their Caregivers: Mixed Methods Study. JMIR Aging. 2024 Dec 18;7:e60117. doi: 10.2196/60117. PubMed 39693573 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Mar 2027, 36 months after the start.

Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 36 months is above that.

Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2023
First posted
Oct 19, 2023
StartActual
Mar 7, 2024
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Apr 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06090734
Lead sponsor
Duke-NUS Graduate Medical School
Collaborators
Changi General Hospital, Singapore General Hospital, Sengkang General Hospital, National Heart Centre Singapore, Khoo Teck Puat Hospital
Responsible party
Chetna Malhotra (Associate Professor, Duke-NUS Graduate Medical School) — Principal investigator
First posted
Oct 19, 2023
Start date
Mar 7, 2024
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Apr 21, 2026

Study contacts

Chetna Malhotra
principal investigator · Duke-NUS Graduate Medical School

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion